TRIM29 and Familial prostate cancer: Despite its oncogenic effect in certain cancers, TRIM29 is also implicated as a tumor suppressor in some types of breast and bone cancers, and is downregulated in breast and prostate cancers, and cisplatin-resistant oral squamous cell carcinoma cell line [21-25].